Donald Trump faces renewed scrutiny over his cognitive fitness as senior medical figures warn of “evident warning signs,” calling for mandatory brain evaluations for leaders with nuclear authority. In a pointed editorial in The BMJ, editor-in-chief Dr Kamran Abbasi challenges Mr Trump’s repeated claims of “perfect” health, noting that his much-vaunted cognitive tests fall well short of a proper neurological assessment.
Dr Abbasi writes: “Trump’s famed cognitive tests, which he ritually declares to have passed with flying colours, fall short of the required full neurological assessment, including a detailed cognitive instrument and a three-dimensional weighted MRI of the head.”
The intervention comes amid recent speculation about the President’s mental sharpness, fuelled by perceived erratic speech patterns. While Mr Trump insists he remains in peak condition, critics have voiced alarm over behaviour that echoes concerns first aired during his first term.
A linked analysis by neurologist Dr David Nicholl and Professor Trish Greenhalgh acknowledges these “warning signs” but strongly cautions against remote diagnosis. They note that a variant of frontotemporal dementia is frequently suggested by observers, yet insist doctors must not diagnose at a distance without proper clinical examination.
Dr Nicholl and Prof Greenhalgh argue: “The Montreal Cognitive Assessment Trump has cited does not equate to a comprehensive neuropsychological profile.” They call for detailed testing and brain scans to properly evaluate any potential decline.
Dr Abbasi’s editorial goes further, questioning whether professional rules like the US Goldwater rule should remain absolute when a leader controls a nuclear arsenal.
Dr Abbasi asks: “How many current leaders with their finger on the button of a nuclear arsenal would we subjectively consider to be rational?”
He links the debate to broader challenges in understanding dementia, referencing recent BMJ publications that highlight the complexity of Alzheimer’s pathways. The piece concludes that society must apply “clear-sighted societal and ethical lenses” to leaders whose decisions can cause mass harm.
Dr Abbasi argues: “Part of the scrutiny for Trump, and other leaders with the power to cause mass death, must be a constitutional requirement for a regular and full evaluation of brain health, bound to a process that prioritises the public’s wellbeing above a leader’s desire to remain in power.”
The concerns echo wider commentary. Democratic lawmakers, including Congressman Jamie Raskin, have previously requested formal neuropsychological assessments, citing “signs consistent with dementia and cognitive decline.” Even some conservative voices have privately expressed unease about the president’s coherence.
Mr Trump’s team has dismissed the speculation as partisan attacks, pointing to his demanding schedule and electoral successes as proof of vigour. His personal physician has previously described his health as excellent.
Yet the BMJ intervention carries weight because it frames the issue as a matter of public safety. It draws parallels with historical cases, such as Winston Churchill’s illnesses, and work by former doctor and politician Lord David Owen on “hubris syndrome” in leaders.
A White House spokesman hit back in a strongly worded statement, saying: “These are false and slanderous allegations from a ‘doctor’ who is unethically speculating on health matters they have no insight into. President Trump’s sharpness, unmatched energy, and historic accessibility stand in stark contrast to what we saw during the past four years when the legacy media intentionally covered up Joe Biden’s serious mental and physical decline from the American people.
“Unlike the Biden White House, President Trump and his entire team have been fully open and transparent about the President’s health, which remains exceptional. Pushing these fake and desperate narratives now about President Trump is why Americans’ trust in the media just fell to a new all-time low.”
